|
Volumn 42, Issue 8, 2015, Pages 1031-
|
Letter: Faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection - Authors' reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIDAXOMICIN;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
BACTERIAL PHENOMENA AND FUNCTIONS;
CLINICAL EFFECTIVENESS;
CLOSTRIDIUM DIFFICILE INFECTION;
COMBINATION CHEMOTHERAPY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DIARRHEA;
DRUG COST;
DRUG EFFICACY;
FECAL MICROBIOTA TRANSPLANTATION;
HUMAN;
LETTER;
OUTCOME ASSESSMENT;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RECURRENT INFECTION;
CLOSTRIDIUM INFECTIONS;
FEMALE;
MALE;
PROCEDURES;
ANTI-BACTERIAL AGENTS;
CLOSTRIDIUM INFECTIONS;
FECAL MICROBIOTA TRANSPLANTATION;
FEMALE;
HUMANS;
MALE;
VANCOMYCIN;
|
EID: 84941695435
PISSN: 02692813
EISSN: 13652036
Source Type: Journal
DOI: 10.1111/apt.13383 Document Type: Letter |
Times cited : (2)
|
References (4)
|